Meet MAIA’s Board of Directors

team

Leigh-Ann Durant, Esq.

Leigh-Ann Durant, Esq., is a senior legal and business executive with more than 24 years of experience in the global pharmaceutical, bio-technology, life sciences and legal sectors, with demonstrated expertise in drug development and commercialization, turning legal strategy into business action, analytical problem solving, strategic thinking, corporate governance, commercial and corporate transactions, legal and regulatory compliance, risk mitigation, and developing innovative solutions to improve business operations and profitability.

For the past decade, Attorney Durant has served at EMD Serono, Inc., the US affiliate of Merck KGaA, Darmstadt, Germany, where she is the Head lawyer for all R&D activities in the US from early development to launch. She has structured, negotiated and closed numerous high-profile, complex strategic collaborations and transactions, in/out-licensing transactions and business development agreements. 

Earlier in her career, Attorney Durant was a Partner at Nixon Peabody LLP, a Global 100 Law Firm, in its Complex Commercial Litigation, Pharma and FDA Practice Groups. For over two decades, Attorney Durant has served on a variety of boards of directors, executive committees and has led various legal and non-profit organizations as President. She has received numerous awards, including the national Top 30 Emerging Leaders in the Pharmaceutical Industry Award and the Massachusetts In-House Leaders In The Law Award, Woman of the Year in Law Award and Top 10 Women Lawyers in Massachusetts Award.

Attorney Durant received a B.A. with a double major with honors in Foreign Affairs/International Relations and Political Science from Miami University, Oxford, OH, and a Juris Doctorate, cum laude, from Suffolk University Law School, Boston, MA.  After law school, she served as the appellate law clerk for the late Chief Justice Joseph R. Weisberger of the Supreme Court of Rhode Island.

Read More
team

Wayne Klohs

Dr. Klohs has over thirty-five years of experience in the pharmaceutical industry with increasing levels of responsibility held in positions across the drug development and discovery spectrum. He currently consults for numerous biotech and pharma companies focused in oncology after retiring from Astellas Pharma Inc. as a Senior Vice President and Global Therapeutic Head for Oncology.

In five years at Astellas, Dr. Klohs helped build Oncology into a global business with several marketed products including Tarceva® and Xtandi® and helped build a robust oncology pipeline through in-licensing, the acquisition of OSI, and internal discovery. He was responsible for the successful filings of NDAs and MAAs for Xtandi (enzalutamide) and Tarceva (sNDA).  Dr. Klohs’s previous experience includes acting head of Oncology Clinical Sciences at Takeda Global R&D and Executive Director of Oncology Drug Development at Pfizer, Inc.  At Takeda, he led both early and late-stage Development Teams in Oncology, while at Pfizer, he was responsible for Development Teams from mid-Discovery through POC with additional experience in NDA filing of pentostatin/Nipent. Dr. Klohs led development teams at Pfizer and Parke-Davis to more than 14 successful IND filings and Phase 1 starts as well as leading late stage programs in biologics including monoclonal antibodies and an oncolytic adenovirus.  Prior to his experience in drug development for oncology, he led discovery efforts at Warner-Lambert/Parke Davis Pharmaceutical Research in oncology for 16 years in a number of areas including antiangiogenic agents, multiple drug resistance, histone deacetylase inhibitors, and antifolates.

Read More
team

Ramiro Guerrero, J.D., LL.M.

Mr. Guerrero is the Founder and CEO of IMPERIO, Inc., a Chicago & Suburban based Real Estate Investment and Brokerage Organization with over 20 years of business experience. He has also been a Venture Capitalist for the past 10 years aiding entrepreneurs and small businesses in their startup ventures. He received his undergraduate B.S. degree in Business/Management from the University of Illinois, his legal training at the Universidad Metropolitana de Monterrey in Monterrey, Mexico and an LL.M. (Master of Laws) in International Law from St. Mary’s University School of Law in San Antonio, Texas and The University of Innsbruck, Austria.
team

Stan V. Smith, Ph.D.

Stan V. Smith, Ph.D., is president of Smith Economics Group, Ltd. in Chicago, providing economic and financial consulting nationwide. Trained at the University of Chicago and specializing in litigation economics, Smith co-authored the first textbook on the subject of economic damages. Smith has served as an adjunct professor at the University of Chicago and at DePaul University College of Law where he created the first course in the nation in forensic economics.
team

Laurentiu Vlad

Laurentiu Vlad is a highly successful entrepreneur has started and grown 2 successful companies, in wholesale and retail as well as the lighting industry. His most recent company, Luminii, is the US market leader in linear lighting, having built projects including One World Trade Center, Uber HQ, Space Needle Seattle, and United Polaris Lounges. Both him and his wife Eva are greatly committed to help bring to patients new, effective treatments for cancer.